Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation chemotherapy combined with […]

A team of mathematicians and pharmaceutical scientists collaborated to identify the major cause of the low accuracy of […]

Updated Date: Tue, 10 Jan 2023 00:00:00 EST

Biosimilar gains MHRA marketing authorisation for use throughout Britain

Industry-first cancer screening technology boosted by biomedical grant funding

For the first time, a study conducted by a research group at the Comprehensive Cancer Centre Vienna of […]

Older knee replacement designs are just as effective as newer models – according to new research from the […]

The German Center for Cardiovascular Research is centralizing its biospecimens collections, which are currently stored at 60 sites. […]

MHRA approval relates to the company’s midlands-based drug development facilities

Major industry names depart leaving UK pricing deal in serious jeopardy